Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal membrane ergosterol-containing lipid bilayer is a specialized cellular structure that defines the boundary of fungal cells and maintains their physiological environment. Ergosterol, the primary sterol component, is essential for regulating membrane fluidity, thickness, and the activity of various membrane-anchored proteins (Source: PubMed, PMID: 29124205). This bilayer acts as a critical target for antifungal therapy because of the structural differences between ergosterol and the cholesterol found in mammalian membranes (Source: NIH, Antifungal Agents). Polyene antibiotics, such as amphotericin B and nystatin, exploit this difference by binding directly to ergosterol to form transmembrane channels or pores (Source: StatPearls, NBK532957). These pores allow the uncontrolled leakage of essential intracellular components, such as potassium and magnesium ions, which disrupts the electrochemical gradient and leads to rapid fungal cell death (Source: Wikipedia, Amphotericin B). Beyond its role in structural integrity, the ergosterol-containing membrane is involved in vital biological processes including vacuole fusion and endocytosis (Source: UniProt). Despite its efficacy as a target, drugs interacting with this bilayer often face challenges related to host toxicity, particularly nephrotoxicity, due to the partial affinity of some agents for human cholesterol (Source: PubMed, PMID: 25135886).
Direct binding to ergosterol molecules within the lipid bilayer, leading to the formation of aqueous transmembrane pores that cause the rapid leakage of essential intracellular ions (such as potassium) and small molecules, resulting in osmotic instability and fungal cell death (Source: StatPearls, NBK532957).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal membrane ergosterol-containing lipid bilayer.